Literature DB >> 22711344

In vitro replication phenotype of a novel (-1G) hepatitis B virus variant associated with HIV co-infection.

Liza M Cabuang1, Tim Shaw, Margaret Littlejohn, Danni Colledge, Vitini Sozzi, Sally Soppe, Nadia Warner, Alex Thompson, Scott Preiss, Natasha Lam, Renae Walsh, Sharon R Lewin, Chloe L Thio, Gail Matthews, Stephen A Locarnini, Peter A Revill.   

Abstract

The -1G mutant HBV is more prevalent in individuals co-infected with HIV/HBV than in individuals infected with HBV alone and in some cases is the dominant virus in circulation. This mutant is created by the deletion of a dGMP (-1G) from the guanine rich homopolymer sequence located at nts 2,085-2,090 (numbering from EcoRI site as position 1) in the HBV core gene. This deletion causes a frameshift generating a premature stop codon at (64) Asn in the HBV core gene (codon 93 in the precore gene), that truncates the precore protein, precursor of the secreted hepatitis B "e" antigen (HBeAg), and the core protein which forms the viral nucleocapsid. However, the replication phenotype of the -1G mutant HBV is unknown. An in vitro cell culture model in which hepatoma cells were transiently transfected with infectious cDNAs was used to show that the -1G mutant HBV is incapable of autonomous replication and, as expected, replication was restored to wild-type (wt) levels by supplying HBV core protein in trans. Although the -1G mutation had no deleterious effect on intracellular HBV-DNA levels, high levels of -1G mutant HBV relative to wt HBV reduced virus secretion and HBeAg secretion relative to empty vector controls. Importantly, the -1G mutant HBV also caused intracellular retention of truncated precore protein in the endoplasmic reticulum (ER) and Golgi apparatus. Together, these effects may be contributing to the increased pathology observed in the setting of HIV/HBV co-infection.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22711344      PMCID: PMC3538154          DOI: 10.1002/jmv.23328

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  29 in total

1.  HBeAg immunostaining of liver tissue in various stages of chronic hepatitis B.

Authors:  M Lindh; K Savage; J Rees; L Garwood; P Horal; G Norkrans; A P Dhillon
Journal:  Liver       Date:  1999-08

2.  Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response.

Authors:  A Bertolotti; Y Zhang; L M Hendershot; H P Harding; D Ron
Journal:  Nat Cell Biol       Date:  2000-06       Impact factor: 28.824

3.  Coinfection of hepatic cell lines with human immunodeficiency virus and hepatitis B virus leads to an increase in intracellular hepatitis B surface antigen.

Authors:  David M Iser; Nadia Warner; Peter A Revill; Ajantha Solomon; Fiona Wightman; Suha Saleh; Megan Crane; Paul U Cameron; Scott Bowden; Tin Nguyen; Cândida F Pereira; Paul V Desmond; Stephen A Locarnini; Sharon R Lewin
Journal:  J Virol       Date:  2010-03-31       Impact factor: 5.103

4.  Bioinformatic analysis of the hepadnavirus e-antigen and its precursor identifies remarkable sequence conservation in all orthohepadnaviruses.

Authors:  Peter Revill; Lilly Yuen; Renae Walsh; Marie Perrault; Stephen Locarnini; Anna Kramvis
Journal:  J Med Virol       Date:  2010-01       Impact factor: 2.327

5.  Interactions between HIV and hepatitis B virus in homosexual men: effects on the natural history of infection.

Authors:  R J Gilson; A E Hawkins; M R Beecham; E Ross; J Waite; M Briggs; T McNally; G E Kelly; R S Tedder; I V Weller
Journal:  AIDS       Date:  1997-04       Impact factor: 4.177

6.  In vitro susceptibilities of wild-type or drug-resistant hepatitis B virus to (-)-beta-D-2,6-diaminopurine dioxolane and 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil.

Authors:  R Chin; T Shaw; J Torresi; V Sozzi; C Trautwein; T Bock; M Manns; H Isom; P Furman; S Locarnini
Journal:  Antimicrob Agents Chemother       Date:  2001-09       Impact factor: 5.191

7.  Reduced secretion of virions and hepatitis B virus (HBV) surface antigen of a naturally occurring HBV variant correlates with the accumulation of the small S envelope protein in the endoplasmic reticulum and Golgi apparatus.

Authors:  Pong Kian Chua; Robert Yung-Liang Wang; Min-Hui Lin; Tetsuya Masuda; Fat-Moon Suk; Chiaho Shih
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

8.  Different types of ground glass hepatocytes in chronic hepatitis B virus infection contain specific pre-S mutants that may induce endoplasmic reticulum stress.

Authors:  Hui-Ching Wang; Han-Chieh Wu; Chien-Fu Chen; Nelson Fausto; Huan-Yao Lei; Ih-Jen Su
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

9.  Identification of a novel hepatitis B virus precore/core deletion mutant in HIV/hepatitis B virus co-infected individuals.

Authors:  Peter A Revill; Margaret Littlejohn; Anna Ayres; Lilly Yuen; Danni Colledge; Angeline Bartholomeusz; Joe Sasaduesz; Sharon R Lewin; Gregory J Dore; Gail V Matthews; Chloe L Thio; Stephen A Locarnini
Journal:  AIDS       Date:  2007-08-20       Impact factor: 4.177

10.  Effect of the G1896A precore mutation on drug sensitivity and replication yield of lamivudine-resistant HBV in vitro.

Authors:  Robert Y m Chen; Ros Edwards; Tim Shaw; Danni Colledge; William E Delaney; Harriet Isom; Scott Bowden; Paul Desmond; Stephen A Locarnini
Journal:  Hepatology       Date:  2003-01       Impact factor: 17.425

View more
  4 in total

Review 1.  The evolving scenario of non-AIDS-defining cancers: challenges and opportunities of care.

Authors:  Emanuela Vaccher; Diego Serraino; Antonino Carbone; Paolo De Paoli
Journal:  Oncologist       Date:  2014-06-26

2.  Downregulation of interleukin-18-mediated cell signaling and interferon gamma expression by the hepatitis B virus e antigen.

Authors:  S Jegaskanda; S H Ahn; N Skinner; A J Thompson; T Ngyuen; J Holmes; R De Rose; M Navis; W R Winnall; M Kramski; G Bernardi; J Bayliss; D Colledge; V Sozzi; K Visvanathan; S A Locarnini; S J Kent; P A Revill
Journal:  J Virol       Date:  2014-05-28       Impact factor: 5.103

3.  In Vitro Studies Show that Sequence Variability Contributes to Marked Variation in Hepatitis B Virus Replication, Protein Expression, and Function Observed across Genotypes.

Authors:  Vitina Sozzi; Renae Walsh; Margaret Littlejohn; Danni Colledge; Kathy Jackson; Nadia Warner; Lilly Yuen; Stephen A Locarnini; Peter A Revill
Journal:  J Virol       Date:  2016-10-28       Impact factor: 5.103

4.  Molecular characterization of HBV strains circulating among the treatment-naive HIV/HBV co-infected patients of eastern India.

Authors:  Debraj Saha; Ananya Pal; Avik Biswas; Rajesh Panigrahi; Neelakshi Sarkar; Dipanwita Das; Jayeeta Sarkar; Subhasish Kamal Guha; Bibhuti Saha; Sekhar Chakrabarti; Runu Chakravarty
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.